Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression

Biochemical and Biophysical Research Communications

Volumn 478, Issue 2, 2016, Pages 811-817

  Fang, Jing ^a   Sun, Cheng Cao ^b   Gong, Cheng ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

KLF2; Long noncoding RNA XIST; Non small cell lung cancer (NSCLC); Proliferation; Tumorigenesis

Indexed keywords

KRUPPEL LIKE FACTOR 2; LONG UNTRANSLATED RNA; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; X INACTIVATE SPECIFIC TRANSCRIPT; EZH2 PROTEIN, HUMAN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; PROTEIN BINDING; XIST NON-CODING RNA;

AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIGENETIC REPRESSION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON SMALL CELL LUNG CANCER; ONCOGENE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; APOPTOSIS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELL LINE;

AGED; APOPTOSIS; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN BINDING; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84994201378     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.08.030     Document Type: Article

References (55)

1. [1] Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10 (2009), 155–159.
2. [2] Orom, U.A., Derrien, T., Beringer, M., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143 (2010), 46–58.
3. [3] Huarte, M., Guttman, M., Feldser, D., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 (2010), 409–419.
4. [4] Geisler, S., Lojek, L., Khalil, A.M., et al. Decapping of long noncoding RNAs regulates inducible genes. Mol. Cell 45 (2012), 279–291.
5. [5] Rinn, J.L., Kertesz, M., Wang, J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129 (2007), 1311–1323.
6. [6] Pandey, G.K., Mitra, S., Subhash, S., et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 26 (2014), 722–737.
7. [7] Garzon, R., Volinia, S., Papaioannou, D., et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 18679–18684.
8. [8] Yang, F., Huo, X.S., Yuan, S.X., et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 49 (2013), 1083–1096.
9. [9] Barnhill, L.M., Williams, R.T., Cohen, O., et al. High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res. 74 (2014), 3753–3763.
10. [10] Yang, F., Zhang, L., Huo, X.S., et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54 (2011), 1679–1689.
11. [11] Prensner, J.R., Iyer, M.K., Balbin, O.A., et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29 (2011), 742–749.
12. [12] Yang, F., Zhang, L., Huo, X.S., et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54 (2011), 1679–1689.
13. [13] Wang, F., Yuan, J.H., Wang, S.B., et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60 (2014), 1278–1290.
14. [14] Yuan, S.X., Wang, J., Yang, F., et al. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma via de-repression of CTNNB1. Hepatology 63 (2016), 499–511.
15. [15] Yuan, S.X., Yang, F., Yang, Y., et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 56 (2012), 2231–2241.
16. [16] Yap, K.L., Li, S., Munoz-Cabello, A.M., et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38 (2010), 662–674.
17. [17] Pasmant, E., Laurendeau, I., Heron, D., et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67 (2007), 3963–3969.
18. [18] Gupta, R.A., Shah, N., Wang, K.C., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 (2010), 1071–1076.
19. [19] Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol. Cell 43 (2011), 904–914.
20. [20] Tsai, M.C., Manor, O., Wan, Y., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329 (2010), 689–693.
21. [21] Yuan, J.H., Yang, F., Wang, F., et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25 (2014), 666–681.
22. [22] de Kok, J.B., Verhaegh, G.W., Roelofs, R.W., et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 62 (2002), 2695–2698.
23. [23] DeSantis, C.E., Lin, C.C., Mariotto, A.B., et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 64 (2014), 252–271.
24. [24] Sanoff, H.K., Sargent, D.J., Campbell, M.E., et al. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J. Clin. Oncol. 26 (2008), 5721–5727.
25. [25] Sung, J.J., Ng, S.C., Chan, F.K., et al. An updated asia pacific consensus recommendations on colorectal cancer screening. Gut 64 (2015), 121–132.
26. [26] Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
27. [27] De Rosa, M., Pace, U., Rega, D., et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol. Rep. 34 (2015), 1087–1096.
28. [28] Sung, J.J., Lau, J.Y., Young, G.P., et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57 (2008), 1166–1176.
29. [29] Rerknimitr, R., Angsuwatcharakon, P., Ratanachu-ek, T., et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J. Gastroenterol. Hepatol. 28 (2013), 593–607.
30. [30] Chen, Z., Li, J.L., Lin, S., et al. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J. Clin. Invest 126 (2016), 2267–2279.
31. [31] Sun, C., Li, S., Zhang, F., et al. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget, 2016.
32. [32] Li, W., Sun, M., Zang, C., et al. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis., 7, 2016, e2225.
33. [33] Zequn, N., Xuemei, Z., Wei, L., et al. The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer. Oncotarget 7 (2016), 18219–18228.
34. [34] Zang, C., Nie, F.Q., Wang, Q., et al. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Oncotarget 7 (2016), 11696–11707.
35. [35] Huang, Y.S., Chang, C.C., Lee, S.S., et al. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Oncotarget, 2016.
36. [36] Zhuang, L.K., Yang, Y.T., Ma, X., et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis., 7, 2016, e2203.
37. [37] Ren, C., Li, X., Wang, T., et al. Functions and mechanisms of long noncoding RNAs in ovarian Cancer. Int. J. Gynecol. Cancer 25 (2015), 566–569.
38. [38] Yao, Y., Ma, J., Xue, Y., et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett. 359 (2015), 75–86.
39. [39] Tantai, J., Hu, D., Yang, Y., et al. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 8 (2015), 7887–7895.
40. [40] Wu, J., Lingrel, J.B., KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 23 (2004), 8088–8096.
41. [41] Zhang, W., Levi, L., Banerjee, P., et al. Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling. Oncotarget 6 (2015), 35830–35842.
42. [42] Sun, C., Yang, C., Xue, R., et al. Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2. J. Appl. Physiol. (1985) 118 (2015), 224–237.
43. [43] Sun, C.C., Li, S.J., Yang, C.L., et al. Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-e2-related factor 2 (Nrf2)-mediated inhibition of NF-kappab signaling pathway. J. Biol. Chem. 290 (2015), 17784–17795.
44. [44] Sun, C., Li, S., Li, D., Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-beta/Smad signaling. J. Appl. Physiol. (1985) 120 (2016), 377–390.
45. [45] Sun, C., Liu, Z., Li, S., et al. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Oncotarget 6 (2015), 25533–25574.
46. [46] Sun, C., Sang, M., Li, S., et al. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget 6 (2015), 39756–39792.
47. [47] Sun, C., Li, S., Li, D., Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget 7 (2016), 35960–35978.
48. [48] Sun, C., Huang, C., Li, S., et al. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Oncotarget 7 (2016), 8341–8359.
49. [49] Sun, C.C., Li, S.J., Zhang, F., et al. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Oncotarget 7 (2016), 21510–21526.
50. [50] Sun, C., Li, S., Yang, C., et al. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6. Biochem Bioph Res. Commun. 471 (2016), 82–88.
51. [51] Nie, F., Yu, X., Huang, M., et al. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget, 2016.
52. [52] Ma, Y., Yang, Y., Wang, F., et al. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. Gut, 2015.
53. [53] Chen, N., Guo, D., Xu, Q., et al. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma. Oncotarget 7 (2016), 11271–11283.
54. [54] Lu, Z., Xiao, Z., Liu, F., et al. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7 (2016), 241–254.
55. [55] Sun, C., Li, S., Zhang, F., et al. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget, 2016.